Frey Daniel, Braun Oliver, Briand Christophe, Vasák Milan, Grütter Markus G
Department of Biochemistry, University of Zürich, Winterthurerstrasse 190, CH-8057 Zürich, Switzerland.
Structure. 2006 May;14(5):901-11. doi: 10.1016/j.str.2006.03.006.
Dimethylarginine dimethylaminohydrolase (DDAH) is involved in the regulation of nitric oxide synthase (NOS) by metabolizing the free endogenous arginine derivatives N(omega)-methyl-L-arginine (MMA) and N(omega),N(omega)-dimethyl-L-arginine (ADMA), which are competitive inhibitors of NOS. Here, we present high-resolution crystal structures of DDAH isoform 1 (DDAH-1) isolated from bovine brain in complex with different inhibitors, including S-nitroso-L-homocysteine and Zn2+, a regulator of this mammalian enzyme. The structure of DDAH-1 consists of a propeller-like fold similar to other arginine-modifying enzymes and a flexible loop, which adopts different conformations and acts as a lid at the entrance of the active site. The orientation and interaction mode of inhibitors in the active site give insight into the regulation and the molecular mechanism of the enzyme. The presented structures provide a basis for the structure-based development of specific DDAH-1 inhibitors that might be useful in the therapeutic treatment of NOS dysfunction-related diseases.
二甲基精氨酸二甲胺水解酶(DDAH)通过代谢游离的内源性精氨酸衍生物N(ω)-甲基-L-精氨酸(MMA)和N(ω),N(ω)-二甲基-L-精氨酸(ADMA)参与一氧化氮合酶(NOS)的调节,这两种物质是NOS的竞争性抑制剂。在此,我们展示了从牛脑中分离出的DDAH同工型1(DDAH-1)与不同抑制剂(包括S-亚硝基-L-高半胱氨酸和Zn2+,这种哺乳动物酶的一种调节剂)形成复合物的高分辨率晶体结构。DDAH-1的结构由一个类似于其他精氨酸修饰酶的螺旋桨样折叠结构和一个柔性环组成,该柔性环采取不同构象并在活性位点入口处充当盖子。抑制剂在活性位点的取向和相互作用模式有助于深入了解该酶的调节和分子机制。所展示的结构为基于结构开发特定的DDAH-1抑制剂提供了基础,这些抑制剂可能对治疗与NOS功能障碍相关的疾病有用。